Article Details
Retrieved on: 2021-03-16 11:21:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities boosted their target price on shares of Eli Lilly and from $215.00 to $225.00 and gave the stock a "buy" rating in a report on Monday.
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here